MRNA)." data-reactid="23" type="text">European stocks climbed on Wednesday as investors assessed positive results from initial trials of an experimental coronavirus vaccine produced by biotechnology firm Moderna (MRNA).The potential vaccine, developed by researchers at the US National Institute of Allergy and Infectious Diseases, provoked a promising immune response and appeared safe in 45 healthy volunteers in an…
Environment 10 July 2020 By Adam Vaughan European bison are set to be introduced to a nature reserve in the UK in 2022WildMedia / Alamy The European bison will be introduced to the UK for the first time outside a zoo, in a move that conservationists hope will regenerate ecosystems and help other animals and…
WASHINGTON (AP) — The number of Americans applying for unemployment benefits in the two months since the coronavirus took hold in the U.S. has swelled to nearly 39 million, the government reported Thursday, even as states from coast to coast gradually reopen their economies and let people go back to work.More than 2.4 million people…
As European leagues prepare to return from the enforced coronavirus break, screening tests are revealing cases in various championships, although, as yet, not calling into question plans to resume playing.Germany still plans to be the first of the five "big" leagues ahead of Spain, England and Italy - France has declared its season over -…
LONDON — Doctors in Britain, Italy, and Spain have been warned to look out for a rare inflammatory condition in children that is possibly linked to the new coronavirus.Earlier this week, Britain’s Paediatric Intensive Care Society issued an alert to doctors noting that, in the past three weeks, there has been an increase in the…
The FDA has cleared the interleukin (IL)-23 inhibitor tildrakizumab (Ilumya) for the treatment of active psoriatic arthritis (PsA) in adults. Sun Pharma announced the approval on October 30. “As an IL-23 inhibitor administered exclusively by a healthcare provider, Ilumya is now an option for adults with active psoriatic arthritis who are unable to self-administer treatment
Millions of Medicare enrollees who buy stand-alone prescription drug plans will see their average monthly premiums rise by 50% in 2027, a new analysis finds. But enrollees can avoid the average increase — from $34 a month to $51 — by switching to lower-cost plans during the program’s open enrollment period, which runs through Dec.
You don't have permission to access "http://www.medpagetoday.com/washington-watch/washington-watch/123652" on this server. Reference #18.d494d817.1793332899.22e6a54f https://errors.edgesuite.net/18.d494d817.1793332899.22e6a54f